PARICALCITOL
Generic: PARICALCITOL
Accord HealthcareManufacturer
INTRAVENOUSRoute
PARICALCITOLActive Substance
2016-02-04Original Approval
PARICALCITOL is FDA application NDA207174, sponsored by ACCORD HLTHCARE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2015-11-04
Paricalcitol Capsules, 1 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, IndFailed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Pa
Class III2015-11-04
Paricalcitol Capsules, 2 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, IndFailed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Pa
Class III2015-11-04
Paricalcitol Capsules, 4 mcg, 30 capsules per bottle, Rx Only, Mfd by: Dr. Reddy's Laboratories Limited, Bachupally, IndFailed Tablet/Capsule Specifications: Product recalled due to reports of breakage and leakage of Pa
Top Reported Reactions
1
CALCIPHYLAXIS
66 reports
2
DEATH
66 reports
3
CHRONIC KIDNEY DISEASE
57 reports
4
RENAL FAILURE
56 reports
5
PNEUMONIA
54 reports
6
DRUG INEFFECTIVE
45 reports
7
NAUSEA
44 reports
8
SEPSIS
41 reports
9
DYSPNOEA
39 reports
10
END STAGE RENAL DISEASE
38 reports